Apr 30, 2023

Phreesia Q1 2024 Earnings Report

Phreesia announced financial results for the fiscal first quarter ended April 30, 2023.

Key Takeaways

Phreesia's total revenue was $83.8 million, a 32% increase compared to the same period last year. The average number of healthcare services clients increased by 31%, while net loss decreased from $51.2 million to $37.5 million.

Total revenue increased by 32% to $83.8 million compared to the same period in the prior year.

The average number of healthcare services clients increased by 31% to 3,309.

Net loss decreased to $37.5 million compared to $51.2 million in the same period in the prior year.

Adjusted EBITDA was negative $13.8 million compared to negative $30.6 million in the same period in the prior year.

Total Revenue
$83.8M
Previous year: $63.4M
+32.3%
EPS
-$0.7
Previous year: -$0.99
-29.3%
Patient Payment Volume
$1.02B
Previous year: $837M
+21.4%
Gross Profit
$52.8M
Previous year: $36.8M
+43.6%
Cash and Equivalents
$150M
Previous year: $269M
-44.4%
Free Cash Flow
-$15M
Previous year: -$35.4M
-57.6%
Total Assets
$354M
Previous year: $459M
-22.9%

Phreesia

Phreesia

Phreesia Revenue by Segment

Forward Guidance

For the full fiscal year 2024 ending January 31, 2024, Phreesia expects revenue to be between $353 million and $356 million, implying year-over-year growth of 26% to 27%. Adjusted EBITDA outlook for fiscal year 2024 is raised to a range of negative $60 million and negative $55 million from a previous range of negative $65 million to negative $60 million.

Positive Outlook

  • Revenue expected to be between $353 million and $356 million for fiscal year 2024.
  • Year-over-year revenue growth of 26% to 27% is expected.
  • Adjusted EBITDA outlook for fiscal year 2024 raised to a range of negative $60 million and negative $55 million.
  • Strong performance in the first quarter contributed to the raised Adjusted EBITDA outlook.
  • Maintaining $500 million revenue target to be achieved by annualizing our highest-revenue quarter in fiscal year 2025.

Challenges Ahead

  • Adjusted EBITDA outlook for fiscal year 2024 remains negative.
  • Uncertainty and potential variability of Other (income) expense, net.
  • Uncertainty and potential variability of (Benefit from) provision for income taxes.
  • Reconciliation of the non-GAAP financial measure outlook to the corresponding GAAP measure is not available without unreasonable effort.
  • Items could have a significant impact on the calculation of GAAP Net income (loss).

Revenue & Expenses

Visualization of income flow from segment revenue to net income